iBio, Inc. (IBIO) CMO submits initial Form 3 with power of attorney

Rhea-AI Filing Summary

iBio, Inc. reports the initial beneficial ownership status of its Chief Medical Officer, Molly Carr, on Form 3. She is identified as an officer with the title Chief Medical Officer, and no share transactions or holdings are listed in the data provided. Remarks reference Exhibit 24 – Power of Attorney, indicating an authorization for actions taken on her behalf.

Key Terms

Power of Attorney

1 terms

Power of Attorney regulatory

"Remarks: Exhibit 24- Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 08/04/2026 - 07:16 AM Accepted by SEC EDGAR 08/04/2026 - 07:15 AM Learn about SEC filing dates

FAQ

What does the iBio (IBIO) Form 3 filing for Molly Carr report?

The Form 3 reports initial beneficial ownership information for iBio’s Chief Medical Officer, Molly Carr. It identifies her officer role and title but shows no reported share transactions or holdings in the provided data.

Who is the reporting person in iBio (IBIO) latest Form 3?

The reporting person is Molly Carr, who serves as Chief Medical Officer of iBio, Inc. The Form 3 identifies her as an officer but includes no buy or sell transactions in the structured data supplied.

Does the iBio (IBIO) Form 3 for Molly Carr show any stock purchases or sales?

No. The structured Form 3 data show no stock purchases or sales for Molly Carr. Transaction counts for buys, sells, and derivative exercises are all zero, indicating no reported trading activity in this report.

Is there a Rule 10b5-1 trading plan noted in iBio (IBIO) CMO’s Form 3?

No trading plan is identified in the data; the Rule 10b5-1 indicator is null. This means the report neither confirms nor denies a plan, and no related footnote is provided in this dataset.

What is the significance of Exhibit 24 in the iBio (IBIO) Form 3 remarks?

The remarks reference “Exhibit 24 – Power of Attorney”, indicating a legal authorization related to Molly Carr. This suggests a Power of Attorney has been granted so designated parties can act on her behalf for Form 3 matters.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Carr Molly

(Last) (First) (Middle)

C/O IBIO, INC.

11750 SORRENTO VALLEY ROAD, SUITE 200

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/31/2026

3. Issuer Name and Ticker or Trading Symbol
iBio, Inc. [ IBIO ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24- Power of Attorney

No securities are beneficially owned.

	/s/ Marc Banjak, Attorney-in-fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)